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Abstract
Background: Inhomogeneity of immune cell distribution in the synovial sublining layer was analyzed in order to
improve our mechanistic understanding of synovial inflammation and explore potential refinements for histological
biomarkers in rheumatoid arthritis (RA) and osteoarthritis (OA).
Methods: Synovial tissue of 20 patients (11 RA, 9 OA) was immunohistochemically stained for macrophages (CD68),
synovial fibroblasts (CD55), T cells (CD3), plasma cells (CD38), endothelial cells (vWF) and mast cells (MCT). The
synovial sublining layer was divided into predefined adjacent zones and fractions of the stained area (SA) were
determined by digital image analysis for each cell marker.
Results: Distribution of CD68, CD55, CD38 and MCT staining of the sublining area was heterogeneous (Friedman
ANOVA p < 0.05). The highest expression for all markers was observed in the upper layer close to the lining layer
with a decrease in the middle and lower sublining. The SA of CD68, CD55 and CD38 was significantly higher in all
layers of RA tissue compared to OA (p < 0.05), except the CD38 fraction of the lower sublining. Based on receiver
operating characteristics analysis, CD68 SA of the total sublining resulted in the highest area under the curve (AUC
0.944, CI 95 % 0.844–1.0, p = 0.001) followed by CD68 in the upper and middle layer respectively (both AUC 0.933,
CI 95 % 0.816–1.0, p = 0.001) in both RA and OA. Linear mixed modelling confirmed significant differences in the SA
of sublining CD68 between OA and RA (p = 0.0042) with a higher concentration of CD68+ towards the lining layer
and more rapid decline towards the periphery of the sublining in RA compared to OA (p = 0.0022).
Conclusions: Immune cells are inhomogeneously distributed within the sublining layer. RA and OA tissue display
differences in the number of CD68 macrophages and differences in CD68 decline within the synovial sublining.
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Background
Histological analysis of the synovial membrane is a
powerful tool for the investigation of pathological
changes in rheumatoid arthritis (RA) in order to elu-
cidate the pathogenic mechanisms involved in the dis-
ease [1]. In addition, the assessment of synovial
biomarkers is quite useful in dose-finding studies, for
the stratification of patient groups, and to identify
new therapeutic targets [2]. Although not part of the
clinical daily routine, the use of synovial biopsies in
certain clinical situations is unquestioned [3–5]. For
instance, CD68-positive macrophages in the sublining
layer have repeatedly been shown to be one of the
best activity markers for RA [6, 7]. Besides macro-
phages, further cells are of major interest in synovial
biopsies: synovial fibroblasts are considered key
players in the pathogenesis of rheumatoid arthritis
[8]. T cells are major components of inflammatory in-
filtrates and trigger autoimmunity in cooperation with
antibody-producing plasma cells [9–11]. Mast cells have
been identified to modulate B cells and produce proin-
flammatory cytokines in RA [12, 13] whereas endothelial
cells function as a marker for increased angiogenesis in in-
flamed tissue [14].
Although the synovial sublining is generally con-
sidered as a whole, we consistently noted inhomo-
geneous distribution of immune cells, particularly
prominent under pathological conditions within this
particular compartment of the synovium. A more
precise definition of the relevant areas within the
sublining layer might improve our pathophysiologic
understanding of inflammatory joint diseases and po-
tentially lead to improved diagnostic usage of synovial bi-
opsies. Thus, we set out to analyze histological
features and the cellular composition of the sublining
layer in more detail.
Methods
Patients and synovial sampling
Synovial tissue was obtained from a total of 20 pa-
tients (11 RA, 9 OA) who underwent synovectomy
(elbow (n = 1), wrist (1), shoulder (1) or total joint re-
placement (11 hips, 6 knees)) at the Department of
Orthopaedics at the River Rhein Center for Rheumatology,
St. Elisabeth Hospital, Meerbusch-Lank, Germany. All
patients diagnosed with RA fulfilled the 2010 American
College of Rheumatology criteria for RA. Osteoarth-
ritis (OA) was diagnosed based on the ACR criteria
for knee or hip OA [15, 16]. All patients gave their
full informed consent. The samples were taken under
visual control from macroscopically inflamed areas,
were immediately snap frozen in tissue-TEK (Sakura
Finetek Germany, Staufen, Germany) and stored at −80°
until further processing.
Histology and immunohistochemistry
Seven-micron sections were obtained from the snap-
frozen tissue and fixed for 10 minutes in 3 % parafor-
maldehyde in phosphate-buffered saline (PBS). After
conventional hematoxylin and eosin (H&E) staining
(Merck, Darmstadt, Germany), synovial morphology was
evaluated for tissue quality and the presence of a
continuous lining layer. The sections were used for the
determination of the synovitis score according to Krenn
[17], which is a semi-quantitative 4-point sum score
assessing the synovial lining layer hypertrophy, inflam-
matory infiltrate and cellular density of resident cells.
For immunohistochemistry, parallel sections were incu-
bated with primary monoclonal mouse antibodies
against CD68, mast cell tryptase (MCT), CD15, CD19,
CD56 (all Dako, Glostrup, Denmark), CD55 (Southern-
Biotech, Birmingham, AL, USA), CD3, CD38, von
Willebrand factor (vWF), CD83 (all BD Biosciences, San
Jose, CA, USA), IgG1 as isotype control (Dako, Glostrup,
Denmark) and secondary antibody of the Dako Real De-
tection System (Dako, Glostrup, Denmark), according to
the manufacturer’s instructions. In three cases tissue
quantity was insufficient for sublining layer analysis of
single antibodies (1 × CD68 (RA), 2 ×MCT (RA, OA)).
Imaging and calculation of stained areas
Sections were photographed at × 200 magnification
(Axioskop 2 plus: Carl Zeiss, Jena, Germany; Nikon DS
Vi 1: Nikon, Düsseldorf, Germany) and stored in TIF
format (resolution of 1600 × 1200, 96 dpi) (Image acqui-
sition software: NIS-Elements F, Nikon). Rectangular re-
gions of interest (ROI) of 500 × 250 pixels (661.5 μm×
330.5 μm) size were created using ImageJ [18] and the
upper sublining ROI was placed adjacent to the lining
layer with the lower layer at greatest distance from the
synovial surface. ROIs for the middle and lower layer
were set contiguously in a row. Visual inspection of all
tissues preceded the definition of the ROIs’ size of 500 ×
250 pixels, which was considered suitable to delineate
each layer separately without including parts of the op-
posite sublining area, especially critical in villous forma-
tions of RA tissue. The lumina of blood vessels within
the selected regions were delineated and subtracted from
the respective layer area still including respective endo-
thelial cells in the analysis. Images were then thre-
sholded to highlight the stained areas but not the
respective isotype controls. After converting the image
into a binary image, the highlighted section was mea-
sured and presented as a fraction of the selected region.
For linear mixed model analysis the three ROIs were di-
vided in half to create six equally sized ROIs. To obtain
representative results, measurements were made from
three different regions of each sample and mean values
were used for statistical analysis.
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Statistical analyses
For continuous scales data are given as mean ± standard
deviation (SD), ordinal data such as the synovitis score is
presented as median and 1st quartile to 3rd quartile
(interquartile range, IQR). Student’s t test for independ-
ent samples and Mann–Whitney U test were used to
compare the two groups as appropriate. Analysis of the
different layers was carried out with Friedman’s two-way
analysis of variance (ANOVA) and Dunn’s post hoc test.
Correlations between the synovitis score and the stained
areas were calculated according to Spearman. Receiver
operating characteristics (ROC) analysis with calculation
of the area under the cure (AUC) was used to examine
the diagnostic value of the evaluated cell markers. Afore-
mentioned statistical analyses were carried out using
IBM SPSS statistics (IBM Corp., Armonk, NY, USA) at a
significance level of α = 0.05. For comparison of the de-
cline in CD68+ staining between OA and RA, we ap-
plied a linear mixed model (LMM) with random
intercept for the CD68+ concentration with following
independent variables: distance of the ROI, disease sta-
tus and interaction between distance and disease status.
For the LMM we used the function PROC MIXED of
SAS 9.3 (SAS Institute Inc., Cary, NC, USA).
Results
Patients’ demographics and clinical features
Eleven patients with RA (nine female, aged 63.5 ±
10.6 years) and nine with OA (six female, aged 69.4 ±
11.1 years) were included in this study. Of the RA pa-
tients three had synovectomy of shoulder, hand and
elbow, respectively. Five underwent total hip replace-
ment and three had a total knee replacement. OA tissue
was obtained from six patients undergoing total hip re-
placement and three cases of total knee replacement.
Demographic and clinical data is summarized in Table 1.
Synovitis score (H&E staining)
On histological analysis of H&E-stained sections, the
median synovitis score was 6 (interquartile range (IQR)
5–7) in RA patients and 3 (IQR 1.5–5) in the OA group
(p = 0.002). The RA group showed significantly higher
numbers for all three subscores, e.g. lining layer, inflam-
matory infiltrate, and cellular density (Table 2).
Next, we were interested to determine if the synovitis
score as a measure of inflammatory activity in the entire
synovial layer is reflected by individual cellular markers
within the sublining layer. Correlation analyses revealed
a moderate to high correlation for the total stained area
of CD68, CD3 and CD55 and the total synovitis score
with its subscores in all patients (RA and OA) except
CD55 and the cellular density. CD38 and MCT total
stained area did not correlate with the synovitis score,
and vWF showed moderate correlation only with the
subscore cellular density (Table 3). Typical histological
findings of RA and OA are exemplified in Fig. 1.
Immune cells are inhomogeneously distributed within the
sublining layer
In order to assess cellular distribution within the sublining
layer, immunohistochemistry was applied to stain for mac-
rophages (CD68), synovial fibroblasts (CD55), T cells
(CD3), plasma cells (CD38), endothelial cells (vWF) and
mast cells (MCT) (Fig. 1). The fraction of stained area was
determined by digital image analysis in three predefined
zones of the sublining layer with the upper layer closest to
the lining layer and the lower layer representing the deeper
sublining. While expression of CD68, CD3, CD55, vWF
and CD38 could be visualized in all cases, MCT was abun-
dant in three tissues (two RA, one OA). Analysis revealed
an inhomogeneous distribution of CD68-, CD55-, CD38-,
and MCT-positive cells (p < 0.05 according to Friedman
two-way ANOVA). Staining of CD19+ B cells, CD15+
granulocytes, CD56+ natural killer cells and CD83+ dendritic
cells was discontinued due to very low expression in both
RA and OA tissue. Details on inhomogeneity of distinct
immune cells within the sublining layer are given in Fig. 2.
The percentage of stained area of CD68, CD3, CD55 and
MCT differs significantly between RA and OA
We then set out to compare cell marker expression be-
tween RA and OA. These analyses revealed significant
Table 1 Demographic and clinical features
All patients RA OA RA vs. OA
n = 20 n = 11 n = 9 p values
Age at surgery, yrs (±SD) 66.2 (±10.9) 63.5 (±10.6) 69.4 (±11.1) 0.233
Female, n (%) 14 (75.0) 9 (81.8) 6 (66.7)
CRP, mg/dl (±SD) 2.5 (±2.7) 3.7 (±3.2) 1.2 (±1.0) 0.001
Leucocytes,/μl (±SD) 8570.0 (±4784.4) 10,654.5 (±5639.0) 6022.2 (±1157.3) 0.001
RF, IU/ml (±SD) 71.5 (±156.9) 126.3 (±198.5) 4.4 (2.4) <0.001
ESR, mm/h, (±SD) 22.2 (±20.9) 29.4 (±23.3) 14.1 (15.3) 0.079
Comparison by Student’s t test, significant results are printed in bold
RA rheumatoid arthritis, OA osteoarthritis, SD standard deviation, CRP C-reactive protein, RF rheumatoid factor, ESR erythrocyte sedimentation rate
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differences between all sublining layers with consistently
higher percentages of staining in RA tissue for the three
parameters CD68, CD55 and CD38. Typical staining pat-
terns in RA and OA are shown in Fig. 2. Results of the
comparison of RA and OA are summarized in Table 4.
CD68 remains the best parameter to distinguish RA from OA
In order to estimate the most reliable parameter for dif-
ferentiation between RA and OA in the current study,
receiver operating characteristics (ROC) analyses with
determination of the area under the curve (AUC) were
performed. CD68 total stained area within the sublining
was identified as the most reliable marker to discrimin-
ate between RA and OA (AUC 0.94, CI 95 % 0.84–1.00,
p = 0.001) followed by the CD68-stained area in the
upper and middle sublining (both AUC 0.93, CI 95 %
0.82–1.00, p = 0.001). Furthermore, staining of CD3
upper layer (AUC 0.86, CI 95 % 0.69–1.00, p = 0.07) and
CD55 middle layer (AUC 0.89, CI 95 % 0.71–1.00, p =
0.03) and the total stained area (CD3: AUC 0.83, CI
95 % 0.64–1.00, p = 0.014; CD55: AUC 0.89, CI 95 %
0.74–1.00, p = 0.03) provided considerable accuracy for
RA tissue, whereas no difference was observed for
CD38, vWF or MCT.
Linear mixed modelling indicates significant differences
in decline of CD68 staining within the synovial sublining
between OA and RA
We set out to further specify the differences in CD68 ex-
pression between OA and RA by modelling the
distribution of CD68-positive cells within the sublining
layer. Three observations can be made: (1) in RA, the
number of positive cells starts on higher level than in
OA (p < 0.0001). (2) For both diseases, the number of
positive cells decreases with growing distance from the
lining layer (p < 0.0001). (3) The decrease is significantly
stronger in RA compared to OA (p = 0.003). Details of
the linear mixed model are outlined in Fig. 3 and
Table 5.
Discussion
The synovial membrane in patients with RA and OA has
been subject to a broad variety of studies, which have
substantially contributed to the elucidation of patho-
genic mechanisms. So far, the lining layer has been in-
tensively studied and histological features in RA such as
hypertrophy and the accumulation of macrophages, fi-
broblasts and giant cells within the lining have been well
described [19]. In this study, we focused on the sublining
layer and the ongoing pathophysiological changes in this
area since important observations have been made in
this zone. In particular, CD68-positive sublining macro-
phages have been identified as a very potent biomarker:
they reflect disease activity [20] and synovial inflamma-
tion in refined magnetic resonance imaging (MRI) pro-
cedures [21]. Most strikingly, changes in sublining CD68
macrophages are a potent biomarker for response to
therapy across academic centres [6], and they are likely
not liable to placebo effects [7]. This renders synovial bi-
opsies a powerful tool in early- phase clinical studies
Table 2 Synovitis score
All patients RA OA RA vs. OA
n = 20 n = 11 n = 9 p values
Synovitis scorea, median (IQR) 5 (3–6) 6 (5–7) 3 (1.5–5) 0.002
Lining layer hypertrophy 1.5 (1–2) 2 (1–3) 1 (0–1.5) 0.025
Inflammatory infiltrate 1.5 (1–3) 3 (1–3) 1 (0.5–1.5) 0.007
Cellular density 2 (1–2) 2 (2–2) 1 (0.5–1.5) 0.002
Comparison by Student’s t test, significant results are printed in bold
RA rheumatoid arthritis, OA osteoarthritis, IQR interquartile range
aSynovitis score according to Krenn and colleagues [17]
Table 3 Correlation between the total stained area of the synovial sublining and the synovitis score
Synovitis scorea Lining layer hypertrophy Inflammatory infiltrate Cellular density
CD68 0.706 (p = 0.001) 0.554 (p = 0.014) 0.604 (p = 0.006) 0.576 (p = 0.010)
CD3 0.852 (p < 0.001) 0.798 (p < 0.001) 0.757 (p < 0.001) 0.601 (p = 0.005)
CD55 0.651 (p = 0.002) 0.622 (p = 0.003) 0.668 (p = 0.001) 0.428 (p = 0.060)
CD38 0.245 (p = 0.298) 0.122 (p = 0.608) 0.154 (p = 0.518) 0.419 (p = 0.066)
vWF 0.437 (p = 0.054) 0.302 (p = 0.195) 0.344 (p = 0.138) 0.576 (p = 0.008)
MCT 0.083 (p = 0.743) 0.362 (p = 0.140) −0.071 (p = 0.780) 0.008 (p = 0.974)
Correlations according to Spearman, significant correlations are printed in bold
CD68 macrophages, CD3 T cells, CD55 synovial fibroblasts, CD38 plasma cells, vWF von Willebrand factor, MCT mast cell tryptase
aSynovitis score according to Krenn and colleagues [17]
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[22]. These findings suggest that the synovial sublining
may also play a substantial role in disease mechanisms
of RA. However, the synovial sublining is ill-defined and
our own circumstantial observations suggested that cel-
lular distribution within this area may be inhomogen-
eous. In the present study, we partitioned the sublining
layer and comprehensively analyzed immune cellular
composition as this might lead to an improved under-
standing of disease mechanisms and potential future re-
finements in its use as a biomarker. We demonstrate a
strikingly inhomogeneous distribution of most immune
cells and fibroblasts within the sublining layer of both
RA and OA tissue with a clear tendency of macrophages
(CD68), synovial fibroblasts (CD55), plasma cells
(CD38), mast cells (MCT) and endothelial cells (vWF)
to accumulate in the upper sublining. Of note, we
refrained from adjusting for multiple testing, because a
low to moderate amount of statistical hypothesis was
tested for the above markers, and because of concerns
for overemphasizing the sensibility of p values [23].
However, as outlined in the tables, some borderline sta-
tistically significant findings would probably not have
crossed the 5 % threshold in case of adjustments. Fur-
thermore, we applied linear mixed modelling to the dis-
tribution of sublining CD68 cells in order to assess
potential regularities in the distribution of macrophages
with distance to the lining layer being the independent
variable. The advantage of this particular model was a
precise and accurate analysis of macrophage allocation
since special focus was set on the distance to the lining
Fig. 1 Typical histologic and immunohistochemical staining patterns of RA and OA synovial tissue. H&E staining reveals an enlarged synovial
lining layer (black arrows), an increased cellular density (hollow arrow) and inflammatory infiltrates (arrowhead) in RA tissue, the findings are less
marked in OA tissue. CD68 and CD55 expression is predominant in the lining layer (black arrow) and upper sublining (white arrowhead) adjacent
to the lining, again more pronounced in RA compared to OA, whereas CD3+ T cells are distributed equally within the sublining. CD38 expression
is observed in the lining layer (black arrow) and vascular structures (*) as well as in lymphocytic infiltrates (arrowhead). vWF and MCT staining is
also more pronounced within the upper lining, although the difference between RA and OA is only mild
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Fig. 2 Differences within the sublining layer for expression of CD68, CD55, CD3, CD38 and MCT in all patients and patients with RA and OA
respectively. Expression of cellular markers was highest in the upper sublining adjacent to the lining layer (blue), with a decrease towards the
middle (green) and lower (fawn) layers within the deeper synovium (except CD3). *Statistically significant; ○outliers; ▼extremes
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taking into account the intra-patient correlations which
were integrated into the statistical calculations [24]. We
found a high accumulation of macrophages towards the
lining layer and a fast decline in RA compared to OA.
Since the lining layer faces the joint cavity, we assume
that rather than the total CD68+ cells within the whole
sublining layer, those in close proximity to the joint cav-
ity are of foremost importance for the inflammatory
joint reaction [25]. This is further supported by looking
at the pathophysiological implications of CD68 homing:
the increase of vWF expression reflects the early dysreg-
ulation of angiogenesis that occurs in inflammatory dis-
orders [26] and is considered to be a prerequisite for
immune cells to enter the synovial membrane [14, 26].
In RA, the process of angiogenesis and the subsequent
recruitment of immune cells and synovial fibroblasts fur-
ther results in the formation of pannus tissue producing
inflammatory cytokines that lead to cartilage and bone
destruction [27]. The close proximity of the respective
immune cells to the lining layer and thus the surface of
the synovial membrane may be an essential step towards
fast pannus formation and consecutive destruction of
adjacent cartilage. We hypothesize that the preferential
presence of CD68+ cells towards the lining layer and the
joint cavity with a rapid decline in the lower layers is
due to an increase in extravasation of precursor cells
from the blood, with more rapid homing towards the
lining layer. Further evidence for this hypothesis is pro-
vided by the significantly higher expression of CD68,
CD55, CD38 and CD3 in RA compared to OA which is
in accordance with destructive pannus formation of RA
being composed of macrophages, synovial fibroblasts,
plasma cells, leucocytes and mast cells [28, 29].
In contrast to all other evaluated immune cells, CD3+
T cells did not have the tendency to accumulate in the
upper sublining, but were distributed homogeneously.
Depending on the inflammatory activity, CD3+ T cells
were either absent, randomly distributed or clustered in
Table 4 Mean percentage of stained area in the synovial sublining
All patients RA OA Mann–Whitney U
(mean ± SD) (mean ± SD) (mean ± SD) (p value)
CD68 Upper 10.52 (±7.75) 15.89 (±6.88) 4.55 (±2.42) 0.001
Middle 7.12 (±7.82) 12.04 (±8.05) 1.66 (±0.89) 0.001
Lower 5.92 (±6.92) 9.85 (±7.66) 1.56 (±1.06) 0.001
Total area 7.85 (±7.33) 12.59 (±7.30) 2.59 (±1.34) <0.001
CD3 Upper 4.79 (±7.74) 8.06 (±8.88) 0.79 (±1.11) 0.006
Middle 4.38 (±6.27) 6.68 (±7.32) 1.58 (±3.22) 0.056
Lower 3.56 (±5.70) 5.86 (±6.91) 0.75 (±1.15) 0.095
Total area 4.24 (±6.05) 6.86 (±7.09) 1.04 (±1.78) 0.012
CD55 Upper 10.80 (±11.93) 15.81 (±13.61) 4.67 (±5.45) 0.012
Middle 4.29 (±5.40) 6.46 (±6.11) 1.64 (±2.86) 0.002
Lower 5.00 (±6.20) 7.73 (±7.21) 1.66 (±1.88) 0.007
Total area 6.70 (±6.59) 10.00 (±7.00) 2.66 (2.92) 0.002
CD38 Upper 5.75 (±4.95) 7.43 (±4.34) 3.68 (±5.10) 0.046
Middle 2.86 (±3.94) 3.97 (±4.55) 1.50 (±2.68) 0.038
Lower 2.74 (±3.85) 3.60 (±4.52) 1.69 (±2.73) 0.175
Total area 3.78 (±4.01) 5.00 (±4.16) 2.29 (±3.47) 0.046
vWF Upper 4.19 (±2.67) 4.87 (±2.77) 3.37 (±2.43) 0.295
Middle 3.84 (±2.92) 4.52 (±2.29) 3.02 (±3.51) 0.175
Lower 2.88 (±2.28) 3.46 (±2.39) 2.18 (±2.06) 0.175
Total area 3.64 (±2.17) 4.28 (±1.94) 2.86 (±2.30) 0.152
MCT Upper 1.53 (±1.53) 1.53 (±1.68) 1.54 (±1.42) 0.897
Middle 0.58 (±0.79) 0.53 (±0.73) 0.64 (±0.91) 0.696
Lower 0.67 (±0.70) 0.66 (±0.59) 0.69 (±0.86) 0.897
Total area 0.93 (±0.90) 0.90 (±0.85) 0.96 (±1.01) 0.829
Comparison of rheumatoid arthritis (RA) and osteoarthritis (OA) by Mann–Whitney U, significant results are shown in bold. Upper layer adjacent to lining layer;
lower layer with greatest distance from lining layer within the deeper synovium
RA rheumatoid arthritis, OA osteoarthritis, SD standard deviation, CD68 macrophages, CD3 T cells, CD55 synovial fibroblasts, CD38 plasma cells, vWF von Willebrand
factor, MCT mast cell tryptase
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follicle-like structures. These follicles, predominant in
RA, spanned the entire sublining resulting in an inten-
sive, but homogeneous staining pattern across all layers.
Our description of different patterns is consistent with
previous studies identifying and defining these histomor-
phological features in RA synovitis as ‘follicular’, ‘diffuse’
and ‘pauci-immune’ [30, 31].
Despite their inhomogeneous distribution patterns, we
observed a moderate to high correlation of total CD68-,
CD3- and CD55- staining in the entire sublining (i.e. not
partitioned into different layers) and the synovitis score
and its components, which has been established as a
valuable tool to assess synovitis activity and to discrim-
inate between low- and high-grade synovitis [17]. These
data on one hand confirm CD68- expression as a valu-
able disease activity parameter and on the other hand
prove the amount of sublining T cells and synovial fibro-
blasts to reflect the grade of synovitis and estimate dis-
ease activity. This again is supported by our finding of
significantly higher expression of immune cell markers
in RA, representing a more inflammatory phenotype
[32] compared to OA.
There are some limitations to this study. Owing to the
lack of any histological criteria clearly defining each
layer, we divided the sublining into three zones of the
same diameter which allowed us to directly compare re-
sults but did not consider interindividual differences re-
garding the extent of the sublining. We considered
potential measurement inaccuracies rather minimal
since ROIs were defined based on extensive study of all
tissues and were set in similar areas adjacent to a
straight lining layer with a sublining area of good tissue
quality. To reduce intraindividual variations, three loci
of each sample were analyzed. Since the patient selection
was made according to clinical diagnosis only, without
regarding other parameters like disease activity, duration
of disease and medication due to ethical restrictions, the
Fig. 3 Linear mixed modelling indicates significant differences in decline of CD68 staining within the synovial sublining between OA and RA. RA
shows a faster decline with distance from the lining layer from ROI 1 towards ROI 6 compared to OA
Table 5 Linear mixed model of CD68+ macrophages spatial
distribution within the synovial sublining: progressive decline in
CD68+ macrophages with distance from the lining layer in OA
and in RA
Effect Disease Estimate Standard
error
p value
Intercept 5.23 1.91 0.003
ROI distance −0.75 0.20 <0.0001
Disease OA 0






RA −0.77 0.27 0.003
Estimates without standard error refer to the reference category
ROI region of interest, OA osteoarthritis, RA rheumatoid arthritis
Mucke et al. Arthritis Research & Therapy  (2016) 18:170 Page 8 of 10
patient population was rather heterogeneous. In spite of
that, results were consistent. Owing to our relatively
small sample size, we did not further subclassify RA
synovitis according to the aforementioned histological
patterns [31, 33]. Furthermore, tissue obtained from ei-
ther joint replacement or synovectomy implies a chronic
or advanced state of disease. Future studies can assess
cellular distribution within the synovial sublining
employing linear mixed modelling in early disease states
and its sensitivity to change following treatment. Hence,
it has to be stressed that CD68 modelling is not yet fit
for reliable diagnostic decision making until further
diagnostic studies in early undifferentiated arthritis, in-
cluding various inflammatory joint conditions, confirm
our results in established RA. Moreover, although im-
mune cell distribution is generally considered to be
comparable between affected joints in polyarticular dis-
ease [34], we cannot fully exclude that differences ob-
served reflect sample site rather than disease state.
Another limitation is that the semi-quantitative digital
image analysis we applied, allowed a selection or de-
selection of single cells only to a limited extent through
the thresholding step. CD38 can be present at low dens-
ity in cells other than plasma cells like NK cells, B cells,
T cells and macrophages so that in non-automated ana-
lyses usually only strong positive cells with the typical
plasma cell morphology are counted [25]. We adjusted
the threshold accordingly; nonetheless CD38 staining
might be overestimated. Moreover, antibodies for immu-
nohistochemistry typically represent the designated tar-
get cell, and are widely used for these purposes [35–37].
However, it should be noted that neither CD55 nor
CD38 or CD68 are exclusively expressed by synovial fi-
broblasts, plasma cells, and macrophages [25, 38].
Conclusions
Macrophages, synovial fibroblasts, plasma cells and mast
cells show an inhomogeneous distribution within the
synovial tissue in both RA and OA with highest concen-
trations in the upper sublining layer. Linear mixed mod-
elling revealed a significantly higher concentration close
to the lining layer with a more rapid decline in RA com-
pared to OA. The model should be further analyzed for
its performance as a biomarker and has pathophysio-
logical implications.
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